NL-OMON50314招募中不适用
ipid storage in Fabry disease and Acid Sphingomyelinase deficiency - Lipid storage in Fabry disease and Acid Sphingomyelinase deficiency
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •General good helath as determined by medical history
- •The individual is willing and able to provide signed informed consent prior to
- •study-related procedures
- •The individual is > 18 years of age, In case of a patient with FD or ASMD: a
- •confirmed diagnosis of FD or ASMD and presence of fibroblasts
排除标准
- •For patients and healthy subjects:
- •- Unwillingness to adhere to study protocol , For healthy subjects only
- •- Medical history of hypercholesterolemia or other lipid disorder
- •- Use of cholesterol lowering medication
研究者
相似试验
进行中（未招募）
不适用
A Study of Migalastat in Fabry DiseaseFabry DiseaseNCT03949920Manchester University NHS Foundation Trust21
Unknown
不适用
Epidemiological Study of Fabry Disease Screening in Chronic Kidney Disease PatientsFabry DiseaseNCT05056636Chang Gung Memorial Hospital2,000
Unknown
4 期
Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry DiseaseFabry DiseaseNCT00487630Assistance Publique - Hôpitaux de Paris34
已完成
不适用
Gastrointestinal involvement in Fabry disease by biopsy using endoscopeFabry diseaseJPRN-UMIN000019954Saitama Medical University Hospital10
已完成
不适用
Survival analysis of Acid Sphingomyelinase deficiency (ASMD) among German patients during childhood to adulthood: a retrospective chart review studyiemann-Pick Disease (acid sphingomyelinase deficiency)DRKS00025852Sanofi Genzyme33